These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9652036)

  • 1. Modulation of the GABAergic tone by benzodiazepine receptor ligands in chronic hepatic encephalopathy in the dog.
    Meyer HP; Rothuizen J
    Vet Q; 1998; 20 Suppl 1():S100-1. PubMed ID: 9652036
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.
    Meyer HP; Legemate DA; van den Brom W; Rothuizen J
    Metab Brain Dis; 1998 Sep; 13(3):241-51. PubMed ID: 9804368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic inhibition of the pituitary release of adrenocorticotropin and alpha-melanotropin is impaired in dogs with hepatic encephalopathy.
    Rothuizen J; de Kok Y; Slob A; Mol JA
    Domest Anim Endocrinol; 1996 Jan; 13(1):59-68. PubMed ID: 8625616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligands.
    Jones EA; Basile AS; Skolnick P
    Adv Exp Med Biol; 1990; 272():121-34. PubMed ID: 1966504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA
    Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors.
    Roy S; Pomier-Layrargues G; Butterworth RF; Huet PM
    Hepatology; 1988; 8(4):845-9. PubMed ID: 2839406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy associated with acquired portacaval shunt in a dog.
    Vulgamott JC
    J Am Vet Med Assoc; 1979 Oct; 175(7):724-6. PubMed ID: 528317
    [No Abstract]   [Full Text] [Related]  

  • 9. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
    Zieve L; Ferenci P; Rzepczynski D; Ebner J; Zimmermann C
    Metab Brain Dis; 1987 Sep; 2(3):201-5. PubMed ID: 2850457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do benzodiazepine ligands contribute to hepatic encephalopathy?
    Jones EA; Basile AS; Yurdaydin C; Skolnich P
    Adv Exp Med Biol; 1993; 341():57-69. PubMed ID: 8116487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theories of the pathogenesis of hepatic encephalopathy.
    Jones EA; Mullen KD
    Clin Liver Dis; 2012 Feb; 16(1):7-26. PubMed ID: 22321462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
    Mullen KD; Martin JV; Mendelson WB; Bassett ML; Jones EA
    Lancet; 1988 Feb; 1(8583):457-9. PubMed ID: 2893876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies.
    Jones EA; Yurdaydin C; Basile AS
    Alcohol Alcohol Suppl; 1993; 2():175-80. PubMed ID: 7748296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA-benzodiazepine receptor complex and drug actions.
    Saano V
    Med Biol; 1987; 65(2-3):167-73. PubMed ID: 2888932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.
    Ahboucha S; Pomier-Layrargues G; Butterworth RF
    Metab Brain Dis; 2004 Dec; 19(3-4):241-51. PubMed ID: 15554420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2005 Dec; 20(4):425-37. PubMed ID: 16382352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
    Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA
    Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.